Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic review.

Stevens SP, Main C, Bailey S, Pizer B, English M, Phillips B, Peet A, Avula S, Wilne S, Wheatley K, Kearns PR, Wilson JS.

Pediatr Blood Cancer. 2018 Nov 8:e27509. doi: 10.1002/pbc.27509. [Epub ahead of print] Review.

PMID:
30408313
2.

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines.

Camero S, Ceccarelli S, De Felice F, Marampon F, Mannarino O, Camicia L, Vescarelli E, Pontecorvi P, Pizer B, Shukla R, Schiavetti A, Mollace MG, Pizzuti A, Tombolini V, Marchese C, Megiorni F, Dominici C.

J Cancer Res Clin Oncol. 2018 Oct 24. doi: 10.1007/s00432-018-2774-6. [Epub ahead of print]

PMID:
30357520
3.

Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group.

Rutkowski S, Modena P, Williamson D, Kerl K, Nysom K, Pizer B, Bartels U, Puget S, Doz F, Michalski A, von Hoff K, Chevignard M, Avula S, Murray MJ, Schönberger S, Czech T, Schouten-van Meeteren AYN, Kordes U, Kramm CM, van Vuurden DG, Hulleman E, Janssens GO, Solanki GA, van Veelen MC, Thomale U, Schuhmann MU, Jones C, Giangaspero F, Figarella-Branger D, Pietsch T, Clifford SC, Pfister SM, Van Gool SW.

Lancet Oncol. 2018 Aug;19(8):e419-e428. doi: 10.1016/S1470-2045(18)30364-4. Review.

PMID:
30102236
4.

The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.

Stevens SP, Main C, Bailey S, Pizer B, English M, Phillips R, Peet A, Avula S, Wilne S, Wheatley K, Kearns PR, Wilson JS.

J Neurooncol. 2018 Sep;139(3):507-522. doi: 10.1007/s11060-018-2901-x. Epub 2018 Jun 9. Review.

5.

Development of a pre-operative scoring system for predicting risk of post-operative paediatric cerebellar mutism syndrome.

Liu JF, Dineen RA, Avula S, Chambers T, Dutta M, Jaspan T, MacArthur DC, Howarth S, Soria D, Quinlan P, Harave S, Ong CC, Mallucci CL, Kumar R, Pizer B, Walker DA.

Br J Neurosurg. 2018 Feb;32(1):18-27. doi: 10.1080/02688697.2018.1431204. Epub 2018 Feb 12.

PMID:
29433337
6.

The use of neo adjuvant single-agent vinblastine for tumour shrinkage in a highly vascular paediatric low-grade glioma.

Stagno V, Mallucci C, Avula S, Pizer B.

Br J Neurosurg. 2018 Feb 6:1-3. doi: 10.1080/02688697.2018.1427212. [Epub ahead of print]

PMID:
29405073
7.

Detection of rotavirus in paediatric oncology patients with diarrhoea: the impact of rotavirus vaccine.

Akhtar T, Cargill J, Gerrard C, Shaw F, Cunliffe NA, Cooke RPD, Pizer B.

J Hosp Infect. 2018 Jun;99(2):185-187. doi: 10.1016/j.jhin.2017.12.022. Epub 2018 Jan 6.

PMID:
29309814
8.

Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery.

Swadi R, Mather G, Pizer BL, Losty PD, See V, Moss D.

BMC Cancer. 2018 Jan 4;18(1):28. doi: 10.1186/s12885-017-3978-x.

9.

Identifying cisplatin-induced kidney damage in paediatric oncology patients.

Barton CD, Pizer B, Jones C, Oni L, Pirmohamed M, Hawcutt DB.

Pediatr Nephrol. 2018 Sep;33(9):1467-1474. doi: 10.1007/s00467-017-3765-6. Epub 2017 Aug 18. Review.

10.

Application of pattern recognition techniques for classification of pediatric brain tumors by in vivo 3T 1 H-MR spectroscopy-A multi-center study.

Zarinabad N, Abernethy LJ, Avula S, Davies NP, Rodriguez Gutierrez D, Jaspan T, MacPherson L, Mitra D, Rose HEL, Wilson M, Morgan PS, Bailey S, Pizer B, Arvanitis TN, Grundy RG, Auer DP, Peet A.

Magn Reson Med. 2018 Apr;79(4):2359-2366. doi: 10.1002/mrm.26837. Epub 2017 Aug 8.

11.

A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma.

Megiorni F, Colaiacovo M, Cialfi S, McDowell HP, Guffanti A, Camero S, Felsani A, Losty PD, Pizer B, Shukla R, Cappelli C, Ferrara E, Pizzuti A, Moles A, Dominici C.

Oncol Rep. 2017 Jul;38(1):3-20. doi: 10.3892/or.2017.5701. Epub 2017 Jun 6.

12.

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.

Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, Rafiee G, Hill RM, Iliasova A, Stone T, Pizer B, Michalski A, Joshi A, Wharton SB, Jacques TS, Bailey S, Williamson D, Clifford SC.

Lancet Oncol. 2017 Jul;18(7):958-971. doi: 10.1016/S1470-2045(17)30243-7. Epub 2017 May 22.

13.

TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.

Thiesen S, Yin P, Jorgensen AL, Zhang JE, Manzo V, McEvoy L, Barton C, Picton S, Bailey S, Brock P, Vyas H, Walker D, Makin G, Bandi S, Pizer B, Hawcutt DB, Pirmohamed M.

Pharmacogenet Genomics. 2017 Jun;27(6):213-222. doi: 10.1097/FPC.0000000000000281. Review.

14.

Midbrain Gliofibroma Presenting in Adulthood following "Cure" of a Childhood Intraventricular Pilocytic Astrocytoma.

Ahmad MU, Barborie A, Pizer B, Husband D, Mallucci C, Jenkinson MD.

Pediatr Neurosurg. 2017;52(3):151-154. doi: 10.1159/000455920. Epub 2017 Mar 1.

PMID:
28245445
15.

The neuroendocrine sequelae of paediatric craniopharyngioma: a 40-year meta-data analysis of 185 cases from three UK centres.

Tan TS, Patel L, Gopal-Kothandapani JS, Ehtisham S, Ikazoboh EC, Hayward R, Aquilina K, Skae M, Thorp N, Pizer B, Didi M, Mallucci C, Blair JC, Gaze MN, Kamaly-Asl I, Spoudeas H, Clayton PE.

Eur J Endocrinol. 2017 Mar;176(3):359-369. doi: 10.1530/EJE-16-0812. Epub 2017 Jan 10.

PMID:
28073908
16.

Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco-regional lymph nodes that responded to chemotherapy.

Ogden S, Harave S, McPartland J, Brennan B, Jeys L, Losty P, Pizer B.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26376. Epub 2016 Dec 24.

PMID:
28012233
17.

Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.

Mynarek M, Pizer B, Dufour C, van Vuurden D, Garami M, Massimino M, Fangusaro J, Davidson T, Gil-da-Costa MJ, Sterba J, Benesch M, Gerber N, Juhnke BO, Kwiecien R, Pietsch T, Kool M, Clifford S, Ellison DW, Giangaspero F, Wesseling P, Gilles F, Gottardo N, Finlay JL, Rutkowski S, von Hoff K.

Neuro Oncol. 2017 Apr 1;19(4):576-585. doi: 10.1093/neuonc/now234.

18.

Post-operative pediatric cerebellar mutism syndrome and its association with hypertrophic olivary degeneration.

Avula S, Spiteri M, Kumar R, Lewis E, Harave S, Windridge D, Ong C, Pizer B.

Quant Imaging Med Surg. 2016 Oct;6(5):535-544.

19.

Clinical value of stool culture in paediatric oncology patients: hospital evaluation and UK survey of practice.

O'Connor O, Cooke RP, Cunliffe NA, Pizer B.

J Hosp Infect. 2017 Jan;95(1):123-125. doi: 10.1016/j.jhin.2016.10.005. Epub 2016 Oct 15.

PMID:
27825673
20.

DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.

Megiorni F, Camero S, Ceccarelli S, McDowell HP, Mannarino O, Marampon F, Pizer B, Shukla R, Pizzuti A, Marchese C, Clerico A, Dominici C.

Oncotarget. 2016 Nov 29;7(48):79342-79356. doi: 10.18632/oncotarget.12688.

Supplemental Content

Loading ...
Support Center